Immunization with a recombinant envelope protein (rgp90) of EIAV produces a spectrum of vaccine efficacy ranging from lack of clinical disease to severe enhancement.

Immunization with a recombinant envelope protein (rgp90) of EIAV produces a spectrum of vaccine efficacy ranging from lack of clinical disease to severe enhancement.

Item
http://www.wikidata.org/entity/Q33502661
Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacyHIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies.Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equidsLymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challengeDivergence, not diversity of an attenuated equine lentivirus vaccine strain correlates with protection from diseaseEnvelope determinants of equine lentiviral vaccine protection.A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses.Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines.CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteinsEvaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horsesA pilot study comparing the development of EIAV Env-specific antibodies induced by DNA/recombinant vaccinia-vectored vaccines and an attenuated Chinese EIAV vaccineViral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen.Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity.Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.Serological method using recombinant S2 protein to differentiate equine infectious anemia virus (EIAV)-infected and EIAV-vaccinated horses.
P2860

Immunization with a recombinant envelope protein (rgp90) of EIAV produces a spectrum of vaccine efficacy ranging from lack of clinical disease to severe enhancement.

Item
http://www.wikidata.org/entity/Q33502661
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Immunization with a recombinan ...... disease to severe enhancement.
@ast
Immunization with a recombinan ...... disease to severe enhancement.
@en
type
label
Immunization with a recombinan ...... disease to severe enhancement.
@ast
Immunization with a recombinan ...... disease to severe enhancement.
@en
prefLabel
Immunization with a recombinan ...... disease to severe enhancement.
@ast
Immunization with a recombinan ...... disease to severe enhancement.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Immunization with a recombinan ...... disease to severe enhancement.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921